Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02689336
Title Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Recruitment Withdrawn
Gender
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

Advanced Solid Tumor

Therapies

Erlotinib + Temozolomide

Age Groups: adult | child
Covered Countries

Additional content available in CKB BOOST